Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

Fig. 3

Kaplan Meyer curves for recurrence free (top row) and overall survival (lower row) stratified by CXCL12 expression. In stage 1 non-seminoma CXCL12 expression did neither predict recurrence free (top left corner) nor overall survival (lower right corner). In metastatic non-seminoma CXCL12 expression predicted recurrence free (top right) but not overall survival (lower right)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us